Bionet (1784.TWO) Stock Price
Bionet Price
Revenue has compounded at 7.4% per year over the past 19 years to 1.24 B TWD. Earnings per share have grown at 1.9% per year over the last 19 years. Bionet's net margin stands at 4.2%, up from 2.9% several years earlier. Bionet currently offers a dividend yield of about 2.50%. The payout ratio is around 139% of earnings. The dividend has grown at 48.0% per year over the past 3 years.
Bionet stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Bionet business model & stock analysis
Frequently asked questions about Bionet
7 analysts currently rate the Bionet stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Bionet to generate revenue of 1.33 B TWD and earnings per share of 1.85 TWD.
Converted at the current exchange rate, the Bionet share trades at 1.56 EUR (56.60 TWD).
The expected revenue of Bionet is 1.33 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Bionet is 92.96 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Bionet is currently 30.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bionet stock.
The price-to-sales ratio (P/S) of Bionet is currently 2.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bionet stock.
The Eulerpool Quality Score for Bionet is 3/10.
The ISIN of Bionet is TW0001784007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Bionet is 1784.TWO. The ticker symbol is used to trade Bionet shares on the stock exchange.
Bionet stock
Bionet Peer Group
Bionet FIGI
All fundamentals and in-depth analysis of Bionet
Our stock analysis for Bionet stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionet. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.